Urvogelbio

Hyderabad, India Founded: 2017 • Age: 9 yrs
Develops innovative exosome-based biomarkers for advanced healthcare applications.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Urvogelbio

Urvogelbio is a company based in Hyderabad (India) founded in 2017 by Sasidhar Manda. It operates as a B2B. Urvogelbio operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.

  • Headquarter Hyderabad, India
  • Founders Sasidhar Manda
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Urvogelbio Private Limited
  • Date of Incorporation 26 Dec, 2017
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Urvogelbio

Premium access

Detailed funding history for Urvogelbio

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Urvogelbio

Investments
Premium access

Investment portfolio details for Urvogelbio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Urvogelbio

Premium access

Detailed financials for Urvogelbio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Urvogelbio Comparisons

Urvogelbio Primary company
Description
Develops innovative exosome-based biomarkers for advanced he...
Location
Hyderabad, India
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Urvogelbio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Urvogelbio

Urvogelbio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Antibody-siRNA complexes are developed for cancer treatment.
Locked Locked Locked
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
Locked Locked Locked
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
Dental implants and regenerative dentistry products are developed.
Locked Locked Locked
RNA-editing technologies are provided for precision medicine applications.
Premium access

Detailed competitors of Urvogelbio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Urvogelbio

Premium access

Complete news archive for Urvogelbio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Urvogelbio

Urvogelbio was founded in 2017.

Urvogelbio is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Urvogelbio operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, biomarkers, and exosome technology. Develops innovative exosome-based biomarkers for advanced healthcare applications. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.

Urvogelbio's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available